Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The transient outward potassium current (Ito) is a fundamental ion current responsible for the early, rapid phase of repolarization (Phase 1) in the cardiac action potential, creating the characteristic notch seen in ventricular and atrial cells (StatPearls, 2023). It is primarily mediated by voltage-gated potassium channels, specifically the Kv4.3 (encoded by KCND3) and Kv4.2 (encoded by KCND2) alpha subunits, which often associate with accessory proteins like KChIP2 to modulate channel kinetics (PubMed, PMID: 11854044). In the heart, Ito density exhibits a transmural gradient, being higher in the epicardium than the endocardium, which contributes to the normal J-wave on an electrocardiogram but can also lead to arrhythmogenic dispersion of repolarization if imbalanced (PubMed, PMID: 15851539). Pathologically, a reduction in Ito is a consistent feature of cardiac remodeling in heart failure and hypertrophy, leading to action potential prolongation and increased risk of triggered activity (PubMed, PMID: 10961943). Conversely, gain-of-function mutations or increased Ito activity are linked to Brugada syndrome and early repolarization syndrome (PubMed, PMID: 24585194). Pharmacological agents such as flecainide, quinidine, and vernakalant interact with these channels, and targeting Ito is a strategy for managing atrial fibrillation, although the lack of absolute specificity can pose risks of pro-arrhythmia or central nervous system effects (PubMed, PMID: 17906270).
Inhibition of the pore-forming alpha subunits (primarily Kv4.3) to block the outward flow of potassium ions during Phase 1 of the action potential, thereby prolonging early repolarization and reducing electrical heterogeneity.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transient outward potassium current (Ito) (Ito).